M. Cebeira

2.1k total citations
23 papers, 1.8k citations indexed

About

M. Cebeira is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, M. Cebeira has authored 23 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cellular and Molecular Neuroscience, 17 papers in Pharmacology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in M. Cebeira's work include Cannabis and Cannabinoid Research (17 papers), Neuroscience and Neuropharmacology Research (15 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). M. Cebeira is often cited by papers focused on Cannabis and Cannabinoid Research (17 papers), Neuroscience and Neuropharmacology Research (15 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). M. Cebeira collaborates with scholars based in Spain, Italy and United States. M. Cebeira's co-authors include Javier Fernández‐Ruíz, J.A. Ramos, Fernando Rodrı́guez de Fonseca, Sara González, Fernando Berrendero, Julián Romero, Jaime A. Ramos, Vincenzo Di Marzo, Tiziana Bisogno and Mariluz Hernández and has published in prestigious journals such as Development, Biochemical and Biophysical Research Communications and Neuroscience.

In The Last Decade

M. Cebeira

23 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Cebeira Spain 18 1.6k 1.2k 302 284 243 23 1.8k
Miguel Navarro Spain 14 1.4k 0.9× 1.0k 0.9× 338 1.1× 253 0.9× 67 0.3× 17 1.7k
M.Clara Sañudo-Peña United States 13 2.6k 1.6× 2.1k 1.8× 758 2.5× 339 1.2× 81 0.3× 16 2.9k
Giuliano Pillolla Italy 23 1.2k 0.8× 1.3k 1.1× 409 1.4× 216 0.8× 72 0.3× 27 2.0k
Leonora E. Long Australia 17 1.0k 0.6× 858 0.7× 260 0.9× 108 0.4× 123 0.5× 21 1.5k
Simona Perra Italy 14 1.0k 0.6× 1.0k 0.9× 308 1.0× 123 0.4× 80 0.3× 14 1.4k
Maria Sabrina Spano Italy 21 817 0.5× 852 0.7× 148 0.5× 186 0.7× 137 0.6× 26 1.4k
Erica Zamberletti Italy 21 1.1k 0.7× 754 0.6× 307 1.0× 93 0.3× 174 0.7× 35 1.4k
Lucı́a Garcı́a-Gil Spain 16 913 0.6× 603 0.5× 168 0.6× 241 0.8× 326 1.3× 16 1.0k
C. Guidali Italy 12 1.3k 0.8× 1.0k 0.9× 272 0.9× 114 0.4× 145 0.6× 12 1.5k
Tibor Wenger Hungary 18 852 0.5× 491 0.4× 206 0.7× 268 0.9× 138 0.6× 27 1.1k

Countries citing papers authored by M. Cebeira

Since Specialization
Citations

This map shows the geographic impact of M. Cebeira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Cebeira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Cebeira more than expected).

Fields of papers citing papers by M. Cebeira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Cebeira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Cebeira. The network helps show where M. Cebeira may publish in the future.

Co-authorship network of co-authors of M. Cebeira

This figure shows the co-authorship network connecting the top 25 collaborators of M. Cebeira. A scholar is included among the top collaborators of M. Cebeira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Cebeira. M. Cebeira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
González, Sara, M. Cebeira, & Javier Fernández‐Ruíz. (2005). Cannabinoid tolerance and dependence: A review of studies in laboratory animals. Pharmacology Biochemistry and Behavior. 81(2). 300–318. 182 indexed citations
2.
Ramos, J.A., Rosario de Miguel, M. Cebeira, Mariluz Hernández, & Javier Fernández‐Ruíz. (2002). Exposure to cannabinoids in the development of endogenous cannabinoid system. Neurotoxicity Research. 4(4). 363–372. 15 indexed citations
3.
Lastres‐Becker, Isabel, Filomena Fezza, M. Cebeira, et al.. (2001). Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease. Neuroreport. 12(10). 2125–2129. 68 indexed citations
4.
Lastres‐Becker, Isabel, M. Cebeira, Marı́a L. de Ceballos, et al.. (2001). Increased cannabinoid CB1 receptor binding and activation of GTP‐binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP‐treated marmosets. European Journal of Neuroscience. 14(11). 1827–1832. 149 indexed citations
5.
Marzo, Vincenzo Di, Fernando Berrendero, Tiziana Bisogno, et al.. (2000). Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9‐Tetrahydrocannabinol‐Tolerant Rats. Journal of Neurochemistry. 74(4). 1627–1635. 149 indexed citations
6.
Berrendero, Fernando, Lucı́a Garcı́a-Gil, Mariluz Hernández, et al.. (1998). Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development. Development. 125(16). 3179–3188. 145 indexed citations
7.
Garcı́a-Gil, Lucı́a, Rosario de Miguel, Riansares Muñoz, et al.. (1997). Perinatal Δ9-Tetrahydrocannabinol Exposure Alters the Responsiveness of Hypothalamic Dopaminergic Neurons to Dopamine-Acting Drugs in Adult Rats. Neurotoxicology and Teratology. 19(6). 477–487. 25 indexed citations
8.
Romero, Julián, Luis García, M. Cebeira, et al.. (1995). The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons. Life Sciences. 56(23-24). 2033–2040. 89 indexed citations
9.
Romero, Julián, Luis Garcı́a-Garcı́a, Javier Fernández‐Ruíz, M. Cebeira, & J.A. Ramos. (1995). Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to δ9-tetrahydrocannabinol. Pharmacology Biochemistry and Behavior. 51(4). 731–737. 89 indexed citations
10.
Fonseca, Fernando Rodrı́guez de, M. Cebeira, Jaime A. Ramos, M. Antonia Martín, & Javier Fernández‐Ruíz. (1994). Cannabinoid receptors in rat brain areas: Sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement. Life Sciences. 54(3). 159–170. 205 indexed citations
11.
Navarro, Miguel, Javier Fernández‐Ruíz, Rosario de Miguel, et al.. (1993). Motor disturbances induced by an acute dose of Δ9-tetrahydrocannabinol: Possible involvement of nigrostriatal dopaminergic alterations. Pharmacology Biochemistry and Behavior. 45(2). 291–298. 66 indexed citations
12.
Bonnin, Ana, J.A. Ramos, Fernando Rodrı́guez de Fonseca, M. Cebeira, & Javier Fernández‐Ruíz. (1993). Acute Effects of Δ<sup>9-</sup>Tetrahydrocannabinol on Tuberoinfundibular Dopamine Activity, Anterior Pituitary Sensitivity to Dopamine and Prolactin Release Vary as a Function of Estrous Cycle. Neuroendocrinology. 58(3). 280–286. 21 indexed citations
13.
Navarro, Miguel, Javier Fernández‐Ruíz, Rosario de Miguel, et al.. (1993). An acute dose of δ9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity. Behavioural Brain Research. 57(1). 37–46. 63 indexed citations
14.
Fonseca, Fernando Rodrı́guez de, Javier Fernández‐Ruíz, Lauren L. Murphy, et al.. (1992). Acute effects of δ-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas. Pharmacology Biochemistry and Behavior. 42(2). 269–275. 61 indexed citations
15.
Navarro, Miguel, Javier Fernández‐Ruíz, Fernando Rodrı́guez de Fonseca, et al.. (1992). Modifications of striatal D2 dopaminergic postsynaptic sensitivity during development of morphine tolerance-dependence in mice. Pharmacology Biochemistry and Behavior. 43(2). 603–608. 25 indexed citations
16.
Fonseca, Fernando Rodrı́guez de, M. Cebeira, Javier Fernández‐Ruíz, Miguel Navarro, & J.A. Ramos. (1991). Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience. 43(2-3). 713–723. 113 indexed citations
17.
Cebeira, M., Mariluz Hernández, Fernando Rodrı́guez de Fonseca, et al.. (1991). Lack of effect of prolactin on the dopaminergic receptor sensitivity in striatal and limbic areas after experimentally-induced alterations in its peripheral levels. Life Sciences. 48(6). 531–541. 7 indexed citations
18.
Fonseca, Fernando Rodrı́guez de, et al.. (1990). Changes in brain dopaminergic indices induced by perinatal exposure to cannabinoids in rats. Developmental Brain Research. 51(2). 237–240. 34 indexed citations
19.
Cebeira, M., et al.. (1987). Role of estrogens on striatal dopaminergic activity. Journal of Steroid Biochemistry. 27(4-6). 683–689. 20 indexed citations
20.
Esquifino, Ana I., Richard W. Steger, Javier Fernández‐Ruíz, et al.. (1987). Catecholaminergic control of plasma growth hormone and thyrotropin levels in hypophysectomized rats bearing ectopic pituitary transplants. Life Sciences. 41(8). 1043–1050. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026